Microbial Cell FactoriesMicrobiologyPeer-reviewed journal article
Dynamics and fermentation patterns of stool microbiota on simple carbon sources in in vitro batch cultures reveal dysbiosis in Crohn's disease.
Anna DetmaniD, Gabriele SchiroiD, Rafał Filip, Emilia SamborowskaiD, Jakub KarczmarskiiD, Sara Jarmakiewicz-CzajaiD, Kinga Jakubowska, Anna Williams, Nicky Hickman, Daniel LaubitziD, Anna SikoraiD
Abstract
Crohns disease (CD)-associated dysbiosis is characterized by reduced microbial diversity, depletion of short-chain fatty acid (SCFA) producers, especially butyrate-forming taxa, and altered metabolic profiles. This study examined whether CD-related dysbiosis is reflected in the fermentation behavior of stool-derived microbial communities cultured in vitro on simple carbon substrates (glucose or acetate+lactate). Shotgun metagenomics and metabolomics revealed that CD-derived communities produced lower levels of butyrate (mainly via lactate and acetate), valerate, caproate, and propionate, and higher levels of ethanol and certain amino acids compared to healthy controls. These metabolic alterations aligned with compositional shifts, including a loss of beneficial commensals (e.g., Coprococcus catus, Ruminococcus torques, Eubacterium rectale, Fusicatenibacter saccharivorans, and Faecalibacterium prausnitzii) and an overrepresentation of CD-associated taxa, particularly Escherichia coli. Metabolic potential analysis revealed an enrichment of genes linked to ethanol and amino acid synthesis in CD-associated microbiotas, underscoring the metabolic adaptability of E. coli. Notably, acetate+lactate substrates supported the growth of healthy microbiota-associated bacteria, whereas glucose favored CD-associated taxa, highlighting disease-specific metabolic imbalances. These findings suggest that in vitro fermentation profiling may help distinguish CD-associated dysbiosis from a healthy microbiome and might support the development of microbiome-informed diagnostic or therapeutic approaches for CD. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=171 SRC="FIGDIR/small/656803v1_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@809890org.highwire.dtl.DTLVardef@a04b89org.highwire.dtl.DTLVardef@1bf39c0org.highwire.dtl.DTLVardef@1687974_HPS_FORMAT_FIGEXP M_FIG C_FIG A short abstract: CD-related dysbiosis alters stool microbial fermentation, reducing butyrate, propionate, valerate, caproate, and increasing ethanol/amino acids in vitro. Fermentation tests may help distinguish CD-associated patterns, suggesting potential for future microbiome-based diagnostics.
- organism: human
- assay: metagenomics
- assay: metabolomics
- research focus: host-pathogen & immune response
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 48th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dominance of metabolically flexible fermenters drives intestinal gas production in Crohn's disease
Astrid KM Stubbusch, Caitlin Welsh, … Chris Greening·bioRxiv·Jun 25, 2026
- Enhanced microbiota profiling in patients with quiescent Crohn's disease through comparison with paired healthy first-degree relatives using fecal metagenomics and metabolomics
Wanning Chen, Yichen Li, … Ruixin Zhu·Cell Reports MedicinePeer-reviewed·Jun 27, 2024
- Systematic interrogation of the distinct metabolic potential in gut microbiomes of inflammatory bowel disease patients with dysbiosis
Almut Heinken, Ines Thiele·bioRxiv·May 17, 2019
- Longitudinal flux balance analyses of a patient with Crohn's disease highlight microbiome metabolic alterations
Arianna Basile, Almut Heinken, … Ines Thiele·bioRxiv·Dec 19, 2022
- Butyrate differentiates permissiveness to Clostridioides difficile infection and influences growth of diverse C. difficile isolates
D. Pensinger, A. T. Fisher, … A. J. Hryckowian·bioRxiv·May 20, 2022
- Profiling the intestinal microbiota, plasma bile acids and inflammation markers reveals novel associations in Crohn's disease and Ulcerative colitis.
Stefanie Prast‐Nielsen, Anna Löf Granström, … Lars G. Engstrand·bioRxiv·Apr 8, 2024